LINAVONKIBART

UNII:	8SSL98OST3
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	LINAVONKIBART
GSRS Full Record:	8SSL98OST3 i

2640981-30-0
Immunoglobulin G4 [228-proline,de-447-lysine], anti-(human transforming growth factor β1 large latent complex) (human monoclonal SRK-181 γ4-chain), disulfide with human monoclonal SRK-181 κ-chain, dimer
Imunoglobulin G4-kappa, anti-[TGFB1 (transforming growth factor beta1, TGF beta)], Homo sapiens monoclonal antibody; gamma4 heavy chain Homo sapiens (1-446) [VH (Homo sapiens IGHV3-48*01 (92.9%) -(IGHD) -IGHJ5*02 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120)-Homo sapiens IGHG4*01,G4v5 h P10, nG4m(a) CH2 L92 (CH1 (121-218), hinge 1-12 S10>P (228) (219-230), CH2 L92 (309)(231-340), CH3 (341-445), CHS K2>del (446))(121-446)], (134-215')-disulfidewith kappa light chain Homo sapiens (1'-215') [V-KAPPA (Homo sapiens IGKV1-33*01 (96.8%) -IGKJ4*01 (100%), CDR-IMGT [6.3.10] (27-32.50-52.89-98)) (1'-108')-Homo sapiens IGKC*01 (100%), Km3 A45.1 (154), V101 (192)(109'-215')]; dimer(226-226'':229-229'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells,glycoform alfa
LINAVONKIBART [USAN]
Linavonkibart
Linavonkibart [WHO-DD]
SRK-181
SRT.BETA.1-AB3
SRT.BETA.1-AB3 (A FULLY HUMAN, ISOFORM-SPECIFIC ANTI-LATENT TGF.BETA.1 ANTIBOD)
linavonkibart [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LINAVONKIBART

Synonyms and Mappings

Resources